• Market Insights
  • Community Data Catalog
  • Integrations
  • API Documentation
    • Documentation Overview
    • Quick start for getting Data
    • Quick start for exporting Data
    • Semantic Query Language
    • Data Source Management API
    • WebHooks API
    • Sentiment Analysis
  • Sign In
  • Sign Up for Free

Sign In

Sign in with Google
Sign in with LinkedIn
Sign in with GitHub
Forgot your password?
Sign up For Free

3 simple steps to get you started

Step 1. Watching this 55 seconds tutorial

Step 2. Get

Your Chrome Extension

Start your 55 seconds tutorial.

Step 3. Get data in a few clicks

Get data from any page you want to get data from.

Need more help?

Need to talk to someone? Contact us—we’d love to help.

3 simple steps to get you started

Step 1. Watching this 55 seconds tutorial

Step 2. Get

Your Chrome Extension

Start your 55 seconds tutorial.

Step 3. Get data in a few clicks

Get data from any page you want to get data from.

Need more help?

Need to talk to someone? Contact us—we’d love to help.

Opps...

We are still busy preparing this batch of data. Please come back in a few minutes.

Hmmm...

Seems like this data source was never ran before...

No changes detected

Changes are only available only when you have ran at least a second time.

Earth calling Mars...?

Nope... guess no Martians around... Maybe set the webhook URL before pressing this button again...

Server response
    

prnewswire.com
All Pharmaceuticals News and Press Releases from PR Newswire

By
Piyush Ruhela
1
Use for Free
  • Data Set Preview
  • Settings
  • Recipe
  • Collaborators
  • Sample Code
Harvested on
100
100
100
CSV JSON HTML Changes
newsreleaseconsolidatelink display-outline w-100-hrefh3remove-outlinesmallno-top-margin remove-outlinelangspanHeadlineColumn 2datecontentHeadlineDateheadlineurlcontentColumn 10origin_patternorigin_urlcreatedAtupdatedAtpingedAt
https://www.prnewswire.com/news-releases/100-cbr-fda-granted-odd-to-biostar-pharm...21 MAR, 2024, 08:30 ET 100% CBR! FDA Granted ODD to Biostar Pharma's Utidelone Ca...Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co.,...21 MAR, 2024, 08:30 ET21 MAR, 2024, 08:30 ET 100% CBR! FDA Granted ODD to Biostar Pharma's Utidelone Ca...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/111-inc-announces-fourth-quarter-and-fis...21 MAR, 2024, 04:47 ET 111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Fi...111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcar...21 MAR, 2024, 04:47 ET21 MAR, 2024, 04:47 ET 111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Fi...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/accent-therapeutics-to-present-data-supp...21 MAR, 2024, 08:00 ET Accent Therapeutics to Present Data Supporting DHX9 and KI...Accent Therapeutics, a biopharmaceutical company pioneering a new class of small ...21 MAR, 2024, 08:00 ET21 MAR, 2024, 08:00 ET Accent Therapeutics to Present Data Supporting DHX9 and KI...Accent Therapeutics, a biopharmaceutical company pioneering a new class of small ...21 MAR, 2024, 08:00 ET Accent Therapeutics to Present Data Supporting DHX9 and KI...21 MAR, 2024, 08:00 ET21 MAR, 2024, 08:00 ET Accent Therapeutics to Present Data Supporting DHX9 and KI...Accent Therapeutics, a biopharmaceutical company pioneering a new class of small ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/american-society-of-pharmacovigilance-am...20 MAR, 2024, 08:44 ET American Society of Pharmacovigilance Amplifies Coordinate...Almost one million Americans have died of adverse drug events, many avoidable, in...20 MAR, 2024, 08:44 ET20 MAR, 2024, 08:44 ET American Society of Pharmacovigilance Amplifies Coordinate...Almost one million Americans have died of adverse drug events, many avoidable, in...20 MAR, 2024, 08:44 ET American Society of Pharmacovigilance Amplifies Coordinate...20 MAR, 2024, 08:44 ET20 MAR, 2024, 08:44 ET American Society of Pharmacovigilance Amplifies Coordinate...Almost one million Americans have died of adverse drug events, many avoidable, in...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/antengene-initiates-phase-ii-dose-expans...20 MAR, 2024, 08:30 ET Antengene Initiates Phase II Dose Expansion Study of Claud...Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ...20 MAR, 2024, 08:30 ET20 MAR, 2024, 08:30 ET Antengene Initiates Phase II Dose Expansion Study of Claud...Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ...20 MAR, 2024, 08:30 ET Antengene Initiates Phase II Dose Expansion Study of Claud...20 MAR, 2024, 08:30 ET20 MAR, 2024, 08:30 ET Antengene Initiates Phase II Dose Expansion Study of Claud...Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/antengene-publishes-preclinical-paper-on...19 MAR, 2024, 20:30 ET Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispe...Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ...19 MAR, 2024, 20:30 ET19 MAR, 2024, 20:30 ET Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispe...Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ...19 MAR, 2024, 20:30 ET Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispe...19 MAR, 2024, 20:30 ET19 MAR, 2024, 20:30 ET Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispe...Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/antennova-completes-first-dosing-cohort-...20 MAR, 2024, 08:30 ET Antennova Completes First Dosing Cohort for Anti-CD24 mAb,...Antennova, a clinical-stage biotech company focused on oncology today announced c...20 MAR, 2024, 08:30 ET20 MAR, 2024, 08:30 ET Antennova Completes First Dosing Cohort for Anti-CD24 mAb,...Antennova, a clinical-stage biotech company focused on oncology today announced c...20 MAR, 2024, 08:30 ET Antennova Completes First Dosing Cohort for Anti-CD24 mAb,...20 MAR, 2024, 08:30 ET20 MAR, 2024, 08:30 ET Antennova Completes First Dosing Cohort for Anti-CD24 mAb,...Antennova, a clinical-stage biotech company focused on oncology today announced c...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/armata-pharmaceuticals-announces-fourth-...21 MAR, 2024, 16:05 ET Armata Pharmaceuticals Announces Fourth Quarter and Full-Y...Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a...21 MAR, 2024, 16:05 ET21 MAR, 2024, 16:05 ET Armata Pharmaceuticals Announces Fourth Quarter and Full-Y...Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a...21 MAR, 2024, 16:05 ET Armata Pharmaceuticals Announces Fourth Quarter and Full-Y...21 MAR, 2024, 16:05 ET21 MAR, 2024, 16:05 ET Armata Pharmaceuticals Announces Fourth Quarter and Full-Y...Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/association-for-diagnostics--laboratory-...21 MAR, 2024, 08:43 ET Association for Diagnostics & Laboratory Medicine (formerl...Statement attributable to: Octavia Peck Palmer, PhD President, Association for Di...21 MAR, 2024, 08:43 ET21 MAR, 2024, 08:43 ET Association for Diagnostics & Laboratory Medicine (formerl...Statement attributable to: Octavia Peck Palmer, PhD President, Association for Di...21 MAR, 2024, 08:43 ET Association for Diagnostics & Laboratory Medicine (formerl...21 MAR, 2024, 08:43 ET21 MAR, 2024, 08:43 ET Association for Diagnostics & Laboratory Medicine (formerl...Statement attributable to: Octavia Peck Palmer, PhD President, Association for Di...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/aurora-cannabis-achieves-australias-tga-...20 MAR, 2024, 07:15 ET Aurora Cannabis Achieves Australia's TGA GMP Certification...Milestone Achievement Signals Company's Commitment to Solidifying its Leadership ...20 MAR, 2024, 07:15 ET20 MAR, 2024, 07:15 ET Aurora Cannabis Achieves Australia's TGA GMP Certification...Milestone Achievement Signals Company's Commitment to Solidifying its Leadership ...20 MAR, 2024, 07:15 ET Aurora Cannabis Achieves Australia's TGA GMP Certification...20 MAR, 2024, 07:15 ET20 MAR, 2024, 07:15 ET Aurora Cannabis Achieves Australia's TGA GMP Certification...Milestone Achievement Signals Company's Commitment to Solidifying its Leadership ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/avidity-biosciences-announces-inducement...21 MAR, 2024, 16:05 ET Avidity Biosciences Announces Inducement Grants Under Nasd...Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to...21 MAR, 2024, 16:05 ET21 MAR, 2024, 16:05 ET Avidity Biosciences Announces Inducement Grants Under Nasd...Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to...21 MAR, 2024, 16:05 ET Avidity Biosciences Announces Inducement Grants Under Nasd...21 MAR, 2024, 16:05 ET21 MAR, 2024, 16:05 ET Avidity Biosciences Announces Inducement Grants Under Nasd...Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/bergenbio-announces-initiation-of-phase-...20 MAR, 2024, 14:13 ET BerGenBio Announces Initiation of Phase 2a in First Line N...BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing...20 MAR, 2024, 14:13 ET20 MAR, 2024, 14:13 ET BerGenBio Announces Initiation of Phase 2a in First Line N...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/bergenbio-announces-initiation-of-phase-...20 MAR, 2024, 14:14 ET BerGenBio Announces Initiation of Phase 2a in First Line N...BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing...20 MAR, 2024, 14:14 ET20 MAR, 2024, 14:14 ET BerGenBio Announces Initiation of Phase 2a in First Line N...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/better-cancer-trials-could-be-around-the...21 MAR, 2024, 11:00 ET Better cancer trials could be around the cornerCold Spring Harbor Laboratory Associate Professor and Cancer Center member Tobias...21 MAR, 2024, 11:00 ET21 MAR, 2024, 11:00 ET Better cancer trials could be around the cornerCold Spring Harbor Laboratory Associate Professor and Cancer Center member Tobias...21 MAR, 2024, 11:00 ET Better cancer trials could be around the corner21 MAR, 2024, 11:00 ET21 MAR, 2024, 11:00 ET Better cancer trials could be around the cornerCold Spring Harbor Laboratory Associate Professor and Cancer Center member Tobias...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/bioforum-expands-leadership-team-with-ap...19 MAR, 2024, 11:00 ET Bioforum Expands Leadership Team with Appointment of Micha...Bioforum, the Data Masters, a leading contract research organization (CRO) focuse...19 MAR, 2024, 11:00 ET19 MAR, 2024, 11:00 ET Bioforum Expands Leadership Team with Appointment of Micha...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/biolinerx-to-report-2023-annual-financia...20 MAR, 2024, 07:00 ET BioLineRx to Report 2023 Annual Financial Results on March...BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical ...20 MAR, 2024, 07:00 ET20 MAR, 2024, 07:00 ET BioLineRx to Report 2023 Annual Financial Results on March...BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical ...20 MAR, 2024, 07:00 ET BioLineRx to Report 2023 Annual Financial Results on March...20 MAR, 2024, 07:00 ET20 MAR, 2024, 07:00 ET BioLineRx to Report 2023 Annual Financial Results on March...BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/biosion-to-present-three-posters-at-the-...21 MAR, 2024, 07:00 ET Biosion to Present Three Posters at the 2024 AACR MeetingBiosion, a global, clinical-stage biotechnology company, today announced upcoming...21 MAR, 2024, 07:00 ET21 MAR, 2024, 07:00 ET Biosion to Present Three Posters at the 2024 AACR Meetinghttps://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/blacksmith-medicines-to-present-at-the-g...19 MAR, 2024, 10:00 ET Blacksmith Medicines to Present at the Gordon Research Con...Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discove...19 MAR, 2024, 10:00 ET19 MAR, 2024, 10:00 ET Blacksmith Medicines to Present at the Gordon Research Con...Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discove...19 MAR, 2024, 10:00 ET Blacksmith Medicines to Present at the Gordon Research Con...19 MAR, 2024, 10:00 ET19 MAR, 2024, 10:00 ET Blacksmith Medicines to Present at the Gordon Research Con...Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discove...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/brazilian-entrepreneur-launches-entourag...20 MAR, 2024, 08:38 ET Brazilian Entrepreneur Launches Entourage Phytolab on One ...Entourage Phytolab, under the leadership of Brazilian entrepreneur Caio Abreu, an...20 MAR, 2024, 08:38 ET20 MAR, 2024, 08:38 ET Brazilian Entrepreneur Launches Entourage Phytolab on One ...Entourage Phytolab, under the leadership of Brazilian entrepreneur Caio Abreu, an...20 MAR, 2024, 08:38 ET Brazilian Entrepreneur Launches Entourage Phytolab on One ...20 MAR, 2024, 08:38 ET20 MAR, 2024, 08:38 ET Brazilian Entrepreneur Launches Entourage Phytolab on One ...Entourage Phytolab, under the leadership of Brazilian entrepreneur Caio Abreu, an...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/cell-expansion-market-worth-26-7-billion...19 MAR, 2024, 10:30 ET Cell Expansion Market Worth $26.7 billion | MarketsandMark...Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion...19 MAR, 2024, 10:30 ET19 MAR, 2024, 10:30 ET Cell Expansion Market Worth $26.7 billion | MarketsandMark...Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion...19 MAR, 2024, 10:30 ET Cell Expansion Market Worth $26.7 billion | MarketsandMark...19 MAR, 2024, 10:30 ET19 MAR, 2024, 10:30 ET Cell Expansion Market Worth $26.7 billion | MarketsandMark...Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/childrens-minnesota-hospital-board-of-di...19 MAR, 2024, 10:00 ET Children's Minnesota Hospital Board of Directors adds new ...Children's Minnesota announced today the appointment of Matt Van Slooten to its h...19 MAR, 2024, 10:00 ET19 MAR, 2024, 10:00 ET Children's Minnesota Hospital Board of Directors adds new ...Children's Minnesota announced today the appointment of Matt Van Slooten to its h...19 MAR, 2024, 10:00 ET Children's Minnesota Hospital Board of Directors adds new ...19 MAR, 2024, 10:00 ET19 MAR, 2024, 10:00 ET Children's Minnesota Hospital Board of Directors adds new ...Children's Minnesota announced today the appointment of Matt Van Slooten to its h...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/china-jo-jo-drugstores-regains-complianc...19 MAR, 2024, 16:05 ET China Jo-Jo Drugstores Regains Compliance with Nasdaq Mini...China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company")...19 MAR, 2024, 16:05 ET19 MAR, 2024, 16:05 ET China Jo-Jo Drugstores Regains Compliance with Nasdaq Mini...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/cognizant-applique-lia-generative-pour-a...19 MAR, 2024, 21:12 ET Cognizant applique l'IA générative pour améliorer la décou...19 MAR, 2024, 21:12 ETCognizant applique l'IA générative pour améliorer la découverte de médicaments po...19 MAR, 2024, 21:12 ET Cognizant applique l'IA générative pour améliorer la décou...19 MAR, 2024, 21:12 ET Cognizant applique l'IA générative pour améliorer la décou...19 MAR, 2024, 21:12 ET19 MAR, 2024, 21:12 ET Cognizant applique l'IA générative pour améliorer la décou...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/cognizant-setzt-generative-ki-ein-um-mit...19 MAR, 2024, 17:45 ET Cognizant setzt generative KI ein, um mit NVIDIA BioNeMo d...19 MAR, 2024, 17:45 ETCognizant setzt generative KI ein, um mit NVIDIA BioNeMo die Arzneimittelforschun...19 MAR, 2024, 17:45 ET Cognizant setzt generative KI ein, um mit NVIDIA BioNeMo d...19 MAR, 2024, 17:45 ET Cognizant setzt generative KI ein, um mit NVIDIA BioNeMo d...19 MAR, 2024, 17:45 ET19 MAR, 2024, 17:45 ET Cognizant setzt generative KI ein, um mit NVIDIA BioNeMo d...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/cognizant-vyuije-generativnu-ai-na-zlepe...19 MAR, 2024, 14:05 ET Cognizant využije generatívnu AI na zlepšenie vývinu lieko...19 MAR, 2024, 14:05 ETCognizant využije generatívnu AI na zlepšenie vývinu liekov pre farmaceutických k...19 MAR, 2024, 14:05 ET Cognizant využije generatívnu AI na zlepšenie vývinu lieko...19 MAR, 2024, 14:05 ET Cognizant využije generatívnu AI na zlepšenie vývinu lieko...19 MAR, 2024, 14:05 ET19 MAR, 2024, 14:05 ET Cognizant využije generatívnu AI na zlepšenie vývinu lieko...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/community-pharmacies-back-in-business-af...20 MAR, 2024, 05:00 ET Community Pharmacies Back In Business After Distributor Cu...You own a small community pharmacy. One day the phone rings and your pharmaceutic...20 MAR, 2024, 05:00 ET20 MAR, 2024, 05:00 ET Community Pharmacies Back In Business After Distributor Cu...You own a small community pharmacy. One day the phone rings and your pharmaceutic...20 MAR, 2024, 05:00 ET Community Pharmacies Back In Business After Distributor Cu...20 MAR, 2024, 05:00 ET20 MAR, 2024, 05:00 ET Community Pharmacies Back In Business After Distributor Cu...You own a small community pharmacy. One day the phone rings and your pharmaceutic...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/corealis-pharma-completes-laboratory-exp...20 MAR, 2024, 15:42 ET Corealis Pharma Completes Laboratory ExpansionCorealis Pharma Inc. is pleased to announce that the expansion project of its sta...20 MAR, 2024, 15:42 ET20 MAR, 2024, 15:42 ET Corealis Pharma Completes Laboratory Expansionhttps://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/dna-sequencing-market-projected-to-reach...21 MAR, 2024, 21:03 ET DNA Sequencing Market Projected to Reach $210.34 billion b...The report titled "DNA Sequencing Market by Product & Services (Consumables, Inst...21 MAR, 2024, 21:03 ET21 MAR, 2024, 21:03 ET DNA Sequencing Market Projected to Reach $210.34 billion b...The report titled "DNA Sequencing Market by Product & Services (Consumables, Inst...21 MAR, 2024, 21:03 ET DNA Sequencing Market Projected to Reach $210.34 billion b...21 MAR, 2024, 21:03 ET21 MAR, 2024, 21:03 ET DNA Sequencing Market Projected to Reach $210.34 billion b...The report titled "DNA Sequencing Market by Product & Services (Consumables, Inst...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/durect-corporation-to-announce-fourth-qu...20 MAR, 2024, 16:30 ET DURECT Corporation to Announce Fourth Quarter and Full Yea...DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneer...20 MAR, 2024, 16:30 ET20 MAR, 2024, 16:30 ET DURECT Corporation to Announce Fourth Quarter and Full Yea...DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneer...20 MAR, 2024, 16:30 ET DURECT Corporation to Announce Fourth Quarter and Full Yea...20 MAR, 2024, 16:30 ET20 MAR, 2024, 16:30 ET DURECT Corporation to Announce Fourth Quarter and Full Yea...DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneer...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/endo-announces-confirmation-of-plan-of-r...19 MAR, 2024, 17:30 ET Endo Announces Confirmation of Plan of ReorganizationEndo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced tha...19 MAR, 2024, 17:30 ET19 MAR, 2024, 17:30 ET Endo Announces Confirmation of Plan of ReorganizationEndo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced tha...19 MAR, 2024, 17:30 ET Endo Announces Confirmation of Plan of Reorganization19 MAR, 2024, 17:30 ET19 MAR, 2024, 17:30 ET Endo Announces Confirmation of Plan of ReorganizationEndo International plc (OTC: ENDPQ) ("Endo" or the "Company") today announced tha...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/europe-laboratory-developed-tests-market...19 MAR, 2024, 10:45 ET Europe Laboratory Developed Tests Market Analysis Report 2...The "Europe Laboratory Developed Tests Market Size, Share & Trends Analysis Repor...19 MAR, 2024, 10:45 ET19 MAR, 2024, 10:45 ET Europe Laboratory Developed Tests Market Analysis Report 2...The "Europe Laboratory Developed Tests Market Size, Share & Trends Analysis Repor...19 MAR, 2024, 10:45 ET Europe Laboratory Developed Tests Market Analysis Report 2...19 MAR, 2024, 10:45 ET19 MAR, 2024, 10:45 ET Europe Laboratory Developed Tests Market Analysis Report 2...The "Europe Laboratory Developed Tests Market Size, Share & Trends Analysis Repor...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/everest-medicines-announces-singapore-he...19 MAR, 2024, 21:03 ET Everest Medicines Announces Singapore Health Sciences Auth...Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutica...19 MAR, 2024, 21:03 ET19 MAR, 2024, 21:03 ET Everest Medicines Announces Singapore Health Sciences Auth...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/fda-approves-nonsteroidal-treatment-for-...21 MAR, 2024, 19:35 ET FDA Approves Nonsteroidal Treatment for Duchenne Muscular ...Today, the U.S. Food and Drug Administration approved Duvyzat (givinostat) oral m...21 MAR, 2024, 19:35 ET21 MAR, 2024, 19:35 ET FDA Approves Nonsteroidal Treatment for Duchenne Muscular ...Today, the U.S. Food and Drug Administration approved Duvyzat (givinostat) oral m...21 MAR, 2024, 19:35 ET FDA Approves Nonsteroidal Treatment for Duchenne Muscular ...21 MAR, 2024, 19:35 ET21 MAR, 2024, 19:35 ET FDA Approves Nonsteroidal Treatment for Duchenne Muscular ...Today, the U.S. Food and Drug Administration approved Duvyzat (givinostat) oral m...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-to-ce...21 MAR, 2024, 08:00 ET FDA Grants Orphan Drug Designation to Cevidoplenib for ITP...Oscotec Inc. has secured orphan drug designation (ODD) from the U.S. Food and Dru...21 MAR, 2024, 08:00 ET21 MAR, 2024, 08:00 ET FDA Grants Orphan Drug Designation to Cevidoplenib for ITP...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/fda-roundup-march-19-2024-302093555.html...19 MAR, 2024, 16:07 ET FDA Roundup: March 19, 2024Today, the U.S. Food and Drug Administration is providing an at-a-glance summary ...19 MAR, 2024, 16:07 ET19 MAR, 2024, 16:07 ET FDA Roundup: March 19, 2024Today, the U.S. Food and Drug Administration is providing an at-a-glance summary ...19 MAR, 2024, 16:07 ET FDA Roundup: March 19, 202419 MAR, 2024, 16:07 ET19 MAR, 2024, 16:07 ET FDA Roundup: March 19, 2024Today, the U.S. Food and Drug Administration is providing an at-a-glance summary ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/flamingo-therapeutics-appoints-leading-m...21 MAR, 2024, 07:00 ET Flamingo Therapeutics Appoints Leading Medical Oncologist ...Flamingo Therapeutics ("Flamingo") today announced the appointment of Ezra Cohen,...21 MAR, 2024, 07:00 ET21 MAR, 2024, 07:00 ET Flamingo Therapeutics Appoints Leading Medical Oncologist ...Flamingo Therapeutics ("Flamingo") today announced the appointment of Ezra Cohen,...21 MAR, 2024, 07:00 ET Flamingo Therapeutics Appoints Leading Medical Oncologist ...21 MAR, 2024, 07:00 ET21 MAR, 2024, 07:00 ET Flamingo Therapeutics Appoints Leading Medical Oncologist ...Flamingo Therapeutics ("Flamingo") today announced the appointment of Ezra Cohen,...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/fusion-pharmaceuticals-reports-fourth-qu...20 MAR, 2024, 16:05 ET Fusion Pharmaceuticals Reports Fourth Quarter and Full Yea...Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company foc...20 MAR, 2024, 16:05 ET20 MAR, 2024, 16:05 ET Fusion Pharmaceuticals Reports Fourth Quarter and Full Yea...Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company foc...20 MAR, 2024, 16:05 ET Fusion Pharmaceuticals Reports Fourth Quarter and Full Yea...20 MAR, 2024, 16:05 ET20 MAR, 2024, 16:05 ET Fusion Pharmaceuticals Reports Fourth Quarter and Full Yea...Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company foc...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/gastroenterology-group-of-naples-introdu...19 MAR, 2024, 10:11 ET Gastroenterology Group of Naples Introduces Innovative Axo...Gastroenterology Group of Naples, a partner practice of United Digestive, is plea...19 MAR, 2024, 10:11 ET19 MAR, 2024, 10:11 ET Gastroenterology Group of Naples Introduces Innovative Axo...Gastroenterology Group of Naples, a partner practice of United Digestive, is plea...19 MAR, 2024, 10:11 ET Gastroenterology Group of Naples Introduces Innovative Axo...19 MAR, 2024, 10:11 ET19 MAR, 2024, 10:11 ET Gastroenterology Group of Naples Introduces Innovative Axo...Gastroenterology Group of Naples, a partner practice of United Digestive, is plea...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/global-hematological-drugs-market-foreca...19 MAR, 2024, 23:15 ET Global Hematological Drugs Market Forecast: Significant Gr...The "Global Hematological Drugs Market (2023-2028) Competitive Analysis, Impact o...19 MAR, 2024, 23:15 ET19 MAR, 2024, 23:15 ET Global Hematological Drugs Market Forecast: Significant Gr...The "Global Hematological Drugs Market (2023-2028) Competitive Analysis, Impact o...19 MAR, 2024, 23:15 ET Global Hematological Drugs Market Forecast: Significant Gr...19 MAR, 2024, 23:15 ET19 MAR, 2024, 23:15 ET Global Hematological Drugs Market Forecast: Significant Gr...The "Global Hematological Drugs Market (2023-2028) Competitive Analysis, Impact o...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/global-menopause-market-analysis-report-...20 MAR, 2024, 18:30 ET Global Menopause Market Analysis Report 2024, Featuring Pr...The "Global Menopause Market Size, Share & Trends Analysis Report by Treatment (D...20 MAR, 2024, 18:30 ET20 MAR, 2024, 18:30 ET Global Menopause Market Analysis Report 2024, Featuring Pr...The "Global Menopause Market Size, Share & Trends Analysis Report by Treatment (D...20 MAR, 2024, 18:30 ET Global Menopause Market Analysis Report 2024, Featuring Pr...20 MAR, 2024, 18:30 ET20 MAR, 2024, 18:30 ET Global Menopause Market Analysis Report 2024, Featuring Pr...The "Global Menopause Market Size, Share & Trends Analysis Report by Treatment (D...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/global-ophthalmic-devices-diagnostics-an...21 MAR, 2024, 05:50 ET Global Ophthalmic Devices, Diagnostics, and Surgical Equip...Ophthalmic Devices, Diagnostics, and Surgical Equipment drive global vision care,...21 MAR, 2024, 05:50 ET21 MAR, 2024, 05:50 ET Global Ophthalmic Devices, Diagnostics, and Surgical Equip...Ophthalmic Devices, Diagnostics, and Surgical Equipment drive global vision care,...21 MAR, 2024, 05:50 ET Global Ophthalmic Devices, Diagnostics, and Surgical Equip...21 MAR, 2024, 05:50 ET21 MAR, 2024, 05:50 ET Global Ophthalmic Devices, Diagnostics, and Surgical Equip...Ophthalmic Devices, Diagnostics, and Surgical Equipment drive global vision care,...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/global-otc-artificial-tears-analysis-rep...21 MAR, 2024, 19:45 ET Global OTC Artificial Tears Analysis Report 2023-2030: The...The "OTC Artificial Tears Market, Size, Global Forecast 2024-2030, Industry Trend...21 MAR, 2024, 19:45 ET21 MAR, 2024, 19:45 ET Global OTC Artificial Tears Analysis Report 2023-2030: The...The "OTC Artificial Tears Market, Size, Global Forecast 2024-2030, Industry Trend...21 MAR, 2024, 19:45 ET Global OTC Artificial Tears Analysis Report 2023-2030: The...21 MAR, 2024, 19:45 ET21 MAR, 2024, 19:45 ET Global OTC Artificial Tears Analysis Report 2023-2030: The...The "OTC Artificial Tears Market, Size, Global Forecast 2024-2030, Industry Trend...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/global-subcutaneous-immunoglobulin-marke...21 MAR, 2024, 19:00 ET Global Subcutaneous Immunoglobulin Market Analysis & Forec...The "Global Subcutaneous Immunoglobulin Market Analysis & Forecast to 2024-2034: ...21 MAR, 2024, 19:00 ET21 MAR, 2024, 19:00 ET Global Subcutaneous Immunoglobulin Market Analysis & Forec...The "Global Subcutaneous Immunoglobulin Market Analysis & Forecast to 2024-2034: ...21 MAR, 2024, 19:00 ET Global Subcutaneous Immunoglobulin Market Analysis & Forec...21 MAR, 2024, 19:00 ET21 MAR, 2024, 19:00 ET Global Subcutaneous Immunoglobulin Market Analysis & Forec...The "Global Subcutaneous Immunoglobulin Market Analysis & Forecast to 2024-2034: ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/global-transfection-technologies-market-...21 MAR, 2024, 13:30 ET Global Transfection Technologies Market Forecast Report to...The "Global Transfection Technologies Market by Product (Kits, Equipment), Method...21 MAR, 2024, 13:30 ET21 MAR, 2024, 13:30 ET Global Transfection Technologies Market Forecast Report to...The "Global Transfection Technologies Market by Product (Kits, Equipment), Method...21 MAR, 2024, 13:30 ET Global Transfection Technologies Market Forecast Report to...21 MAR, 2024, 13:30 ET21 MAR, 2024, 13:30 ET Global Transfection Technologies Market Forecast Report to...The "Global Transfection Technologies Market by Product (Kits, Equipment), Method...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/good-for-business-ptcb-launches-series-h...19 MAR, 2024, 09:00 ET Good for Business: PTCB Launches Series Highlighting Emplo...The Pharmacy Technician Certification Board (PTCB) has launched a new series prof...19 MAR, 2024, 09:00 ET19 MAR, 2024, 09:00 ET Good for Business: PTCB Launches Series Highlighting Emplo...The Pharmacy Technician Certification Board (PTCB) has launched a new series prof...19 MAR, 2024, 09:00 ET Good for Business: PTCB Launches Series Highlighting Emplo...19 MAR, 2024, 09:00 ET19 MAR, 2024, 09:00 ET Good for Business: PTCB Launches Series Highlighting Emplo...The Pharmacy Technician Certification Board (PTCB) has launched a new series prof...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/hanall-biopharma-reports-full-year-2023-...21 MAR, 2024, 07:00 ET HanAll Biopharma Reports Full-Year 2023 Financial Results ...HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company c...21 MAR, 2024, 07:00 ET21 MAR, 2024, 07:00 ET HanAll Biopharma Reports Full-Year 2023 Financial Results ...HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company c...21 MAR, 2024, 07:00 ET HanAll Biopharma Reports Full-Year 2023 Financial Results ...21 MAR, 2024, 07:00 ET21 MAR, 2024, 07:00 ET HanAll Biopharma Reports Full-Year 2023 Financial Results ...HanAll Biopharma Co., Ltd. (KRX: 009420.KS), a global biopharmaceutical company c...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/healthme-and-galenusrx-forge-strategic-p...20 MAR, 2024, 08:22 ET healthŌme and GalenusRx Forge Strategic Partnership to Lau...healthŌme®, Inc., a leading genomics-based, precision health management company s...20 MAR, 2024, 08:22 ET20 MAR, 2024, 08:22 ET healthŌme and GalenusRx Forge Strategic Partnership to Lau...healthŌme®, Inc., a leading genomics-based, precision health management company s...20 MAR, 2024, 08:22 ET healthŌme and GalenusRx Forge Strategic Partnership to Lau...20 MAR, 2024, 08:22 ET20 MAR, 2024, 08:22 ET healthŌme and GalenusRx Forge Strategic Partnership to Lau...healthŌme®, Inc., a leading genomics-based, precision health management company s...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/henlius-2023-annual-results-revenue-surp...21 MAR, 2024, 07:53 ET Henlius 2023 Annual Results: Revenue surpassed RMB5.39 bil...Henlius (2696.HK) announced its 2023 annual results. During the reporting period,...21 MAR, 2024, 07:53 ET21 MAR, 2024, 07:53 ET Henlius 2023 Annual Results: Revenue surpassed RMB5.39 bil...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/hi-bio-receives-fda-orphan-drug-designat...21 MAR, 2024, 08:00 ET HI-Bio Receives FDA Orphan Drug Designation for Felzartama...Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company de...21 MAR, 2024, 08:00 ET21 MAR, 2024, 08:00 ET HI-Bio Receives FDA Orphan Drug Designation for Felzartama...Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company de...21 MAR, 2024, 08:00 ET HI-Bio Receives FDA Orphan Drug Designation for Felzartama...21 MAR, 2024, 08:00 ET21 MAR, 2024, 08:00 ET HI-Bio Receives FDA Orphan Drug Designation for Felzartama...Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company de...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/im-cannabis-to-report-fourth-quarter-and...20 MAR, 2024, 07:00 ET IM Cannabis to Report Fourth Quarter and Full Year 2023 Fi...IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IM...20 MAR, 2024, 07:00 ET20 MAR, 2024, 07:00 ET IM Cannabis to Report Fourth Quarter and Full Year 2023 Fi...IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IM...20 MAR, 2024, 07:00 ET IM Cannabis to Report Fourth Quarter and Full Year 2023 Fi...20 MAR, 2024, 07:00 ET20 MAR, 2024, 07:00 ET IM Cannabis to Report Fourth Quarter and Full Year 2023 Fi...IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IM...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/immunic-receives-notice-of-allowance-for...20 MAR, 2024, 06:30 ET Immunic Receives Notice of Allowance for Composition-of-Ma...Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipel...20 MAR, 2024, 06:30 ET20 MAR, 2024, 06:30 ET Immunic Receives Notice of Allowance for Composition-of-Ma...Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipel...20 MAR, 2024, 06:30 ET Immunic Receives Notice of Allowance for Composition-of-Ma...20 MAR, 2024, 06:30 ET20 MAR, 2024, 06:30 ET Immunic Receives Notice of Allowance for Composition-of-Ma...Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipel...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/immuno-oncology-therapies-in-depth-analy...20 MAR, 2024, 21:45 ET Immuno-Oncology Therapies: In-Depth Analysis of the Rapidl...The "Innovation Waves in Immuno-oncology Therapy Development" report has been add...20 MAR, 2024, 21:45 ET20 MAR, 2024, 21:45 ET Immuno-Oncology Therapies: In-Depth Analysis of the Rapidl...The "Innovation Waves in Immuno-oncology Therapy Development" report has been add...20 MAR, 2024, 21:45 ET Immuno-Oncology Therapies: In-Depth Analysis of the Rapidl...20 MAR, 2024, 21:45 ET20 MAR, 2024, 21:45 ET Immuno-Oncology Therapies: In-Depth Analysis of the Rapidl...The "Innovation Waves in Immuno-oncology Therapy Development" report has been add...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/innovent-announces-2023-annual-results-a...20 MAR, 2024, 07:41 ET Innovent Announces 2023 Annual Results and Business Update...Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutica...20 MAR, 2024, 07:41 ET20 MAR, 2024, 07:41 ET Innovent Announces 2023 Annual Results and Business Update...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/iron-drugs-market-size-to-grow-by-usd-3-...21 MAR, 2024, 22:24 ET Iron Drugs Market size to grow by USD 3.55 billion from 20...The iron drugs market is set to experience substantial growth between 2023 and 20...21 MAR, 2024, 22:24 ET21 MAR, 2024, 22:24 ET Iron Drugs Market size to grow by USD 3.55 billion from 20...The iron drugs market is set to experience substantial growth between 2023 and 20...21 MAR, 2024, 22:24 ET Iron Drugs Market size to grow by USD 3.55 billion from 20...21 MAR, 2024, 22:24 ET21 MAR, 2024, 22:24 ET Iron Drugs Market size to grow by USD 3.55 billion from 20...The iron drugs market is set to experience substantial growth between 2023 and 20...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/jco-precision-oncology-jco-po-publishes-...21 MAR, 2024, 16:00 ET JCO® Precision Oncology (JCO PO) Publishes Study Demonstra...OncoHost, a technology company transforming the approach to precision medicine fo...21 MAR, 2024, 16:00 ET21 MAR, 2024, 16:00 ET JCO® Precision Oncology (JCO PO) Publishes Study Demonstra...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/labcorp-launches-ptau217-blood-biomarker...20 MAR, 2024, 07:00 ET Labcorp Launches pTau217 Blood Biomarker Test to Accelerat...Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory se...20 MAR, 2024, 07:00 ET20 MAR, 2024, 07:00 ET Labcorp Launches pTau217 Blood Biomarker Test to Accelerat...Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory se...20 MAR, 2024, 07:00 ET Labcorp Launches pTau217 Blood Biomarker Test to Accelerat...20 MAR, 2024, 07:00 ET20 MAR, 2024, 07:00 ET Labcorp Launches pTau217 Blood Biomarker Test to Accelerat...Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory se...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/m8-pharmaceuticals-an-acino-company-sign...20 MAR, 2024, 10:00 ET M8 Pharmaceuticals, an Acino company, signs an exclusive a...M8 Pharmaceuticals, an Acino company ("M8") and SERB Pharmaceuticals ("SERB"), a ...20 MAR, 2024, 10:00 ET20 MAR, 2024, 10:00 ET M8 Pharmaceuticals, an Acino company, signs an exclusive a...M8 Pharmaceuticals, an Acino company ("M8") and SERB Pharmaceuticals ("SERB"), a ...20 MAR, 2024, 10:00 ET M8 Pharmaceuticals, an Acino company, signs an exclusive a...20 MAR, 2024, 10:00 ET20 MAR, 2024, 10:00 ET M8 Pharmaceuticals, an Acino company, signs an exclusive a...M8 Pharmaceuticals, an Acino company ("M8") and SERB Pharmaceuticals ("SERB"), a ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/mabwell-presented-iddc-platform-technolo...21 MAR, 2024, 02:11 ET Mabwell Presented IDDC™ Platform Technology and ADC Drug D...Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire i...21 MAR, 2024, 02:11 ET21 MAR, 2024, 02:11 ET Mabwell Presented IDDC™ Platform Technology and ADC Drug D...Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire i...21 MAR, 2024, 02:11 ET Mabwell Presented IDDC™ Platform Technology and ADC Drug D...21 MAR, 2024, 02:11 ET21 MAR, 2024, 02:11 ET Mabwell Presented IDDC™ Platform Technology and ADC Drug D...Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire i...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/manufacturing-execution-system-in-life-s...19 MAR, 2024, 18:15 ET Manufacturing Execution System in Life Sciences Market Rep...The "Manufacturing Execution System in Life Sciences Market Size, Share & Trends ...19 MAR, 2024, 18:15 ET19 MAR, 2024, 18:15 ET Manufacturing Execution System in Life Sciences Market Rep...The "Manufacturing Execution System in Life Sciences Market Size, Share & Trends ...19 MAR, 2024, 18:15 ET Manufacturing Execution System in Life Sciences Market Rep...19 MAR, 2024, 18:15 ET19 MAR, 2024, 18:15 ET Manufacturing Execution System in Life Sciences Market Rep...The "Manufacturing Execution System in Life Sciences Market Size, Share & Trends ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/medical-device-contract-manufacturing-ma...20 MAR, 2024, 10:30 ET Medical Device Contract Manufacturing Market Worth $149.4 ...Medical Device Contract Manufacturing Market in terms of revenue was estimated to...20 MAR, 2024, 10:30 ET20 MAR, 2024, 10:30 ET Medical Device Contract Manufacturing Market Worth $149.4 ...Medical Device Contract Manufacturing Market in terms of revenue was estimated to...20 MAR, 2024, 10:30 ET Medical Device Contract Manufacturing Market Worth $149.4 ...20 MAR, 2024, 10:30 ET20 MAR, 2024, 10:30 ET Medical Device Contract Manufacturing Market Worth $149.4 ...Medical Device Contract Manufacturing Market in terms of revenue was estimated to...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/methotrexate-drug-demand-soaring-due-to-...19 MAR, 2024, 10:15 ET Methotrexate Drug Demand Soaring Due to Chronic Disease Bu...Future Market Insights anticipates the methotrexate drug market to reach US$621.3...19 MAR, 2024, 10:15 ET19 MAR, 2024, 10:15 ET Methotrexate Drug Demand Soaring Due to Chronic Disease Bu...Future Market Insights anticipates the methotrexate drug market to reach US$621.3...19 MAR, 2024, 10:15 ET Methotrexate Drug Demand Soaring Due to Chronic Disease Bu...19 MAR, 2024, 10:15 ET19 MAR, 2024, 10:15 ET Methotrexate Drug Demand Soaring Due to Chronic Disease Bu...Future Market Insights anticipates the methotrexate drug market to reach US$621.3...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/mike-grey-appointed-executive-chair-of-t...21 MAR, 2024, 06:30 ET Mike Grey appointed Executive Chair of Theolytics' Board o...Theolytics, a biotechnology company developing category changing cancer therapies...21 MAR, 2024, 06:30 ET21 MAR, 2024, 06:30 ET Mike Grey appointed Executive Chair of Theolytics' Board o...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/mira-pharmaceuticals-welcomes-dr-itzchak...21 MAR, 2024, 11:04 ET MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former He...MIRA Pharmaceuticals Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), an innovative...21 MAR, 2024, 11:04 ET21 MAR, 2024, 11:04 ET MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former He...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/moasc-presents-cary-presant-md-young-inv...19 MAR, 2024, 11:14 ET MOASC Presents Cary Presant, MD Young Investigator AwardThe Medical Oncology Association of Southern California, Inc. (MOASC), a Californ...19 MAR, 2024, 11:14 ET19 MAR, 2024, 11:14 ET MOASC Presents Cary Presant, MD Young Investigator AwardThe Medical Oncology Association of Southern California, Inc. (MOASC), a Californ...19 MAR, 2024, 11:14 ET MOASC Presents Cary Presant, MD Young Investigator Award19 MAR, 2024, 11:14 ET19 MAR, 2024, 11:14 ET MOASC Presents Cary Presant, MD Young Investigator AwardThe Medical Oncology Association of Southern California, Inc. (MOASC), a Californ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/model-medicines-discovers-new-pan-antivi...20 MAR, 2024, 08:00 ET Model Medicines Discovers New Pan-Antiviral Chemical Entit...Model Medicines, a leading human health company specializing in generative AI-dri...20 MAR, 2024, 08:00 ET20 MAR, 2024, 08:00 ET Model Medicines Discovers New Pan-Antiviral Chemical Entit...Model Medicines, a leading human health company specializing in generative AI-dri...20 MAR, 2024, 08:00 ET Model Medicines Discovers New Pan-Antiviral Chemical Entit...20 MAR, 2024, 08:00 ET20 MAR, 2024, 08:00 ET Model Medicines Discovers New Pan-Antiviral Chemical Entit...Model Medicines, a leading human health company specializing in generative AI-dri...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/molecular-robotics-market-share-analysis...21 MAR, 2024, 12:45 ET Molecular Robotics Market Share Analysis, Industry Trends ...The "Molecular Robotics - Market Share Analysis, Industry Trends & Statistics, Gr...21 MAR, 2024, 12:45 ET21 MAR, 2024, 12:45 ET Molecular Robotics Market Share Analysis, Industry Trends ...The "Molecular Robotics - Market Share Analysis, Industry Trends & Statistics, Gr...21 MAR, 2024, 12:45 ET Molecular Robotics Market Share Analysis, Industry Trends ...21 MAR, 2024, 12:45 ET21 MAR, 2024, 12:45 ET Molecular Robotics Market Share Analysis, Industry Trends ...The "Molecular Robotics - Market Share Analysis, Industry Trends & Statistics, Gr...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/moleculin-to-report-full-year-2023-finan...20 MAR, 2024, 07:30 ET Moleculin to Report Full Year 2023 Financial Results on Ma...Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinica...20 MAR, 2024, 07:30 ET20 MAR, 2024, 07:30 ET Moleculin to Report Full Year 2023 Financial Results on Ma...Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinica...20 MAR, 2024, 07:30 ET Moleculin to Report Full Year 2023 Financial Results on Ma...20 MAR, 2024, 07:30 ET20 MAR, 2024, 07:30 ET Moleculin to Report Full Year 2023 Financial Results on Ma...Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinica...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/neuroderm----nd0612---boundless--3020935...19 MAR, 2024, 15:16 ET NeuroDerm: результаты исследования терапии ND0612 при Парк...19 MAR, 2024, 15:16 ETNeuroDerm: результаты исследования терапии ND0612 при Паркинсоне (BouNDless) поло...19 MAR, 2024, 15:16 ET NeuroDerm: результаты исследования терапии ND0612 при Парк...19 MAR, 2024, 15:16 ET NeuroDerm: результаты исследования терапии ND0612 при Парк...19 MAR, 2024, 15:16 ET19 MAR, 2024, 15:16 ET NeuroDerm: результаты исследования терапии ND0612 при Парк...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/neuroderm-annonce-la-publication-des-res...19 MAR, 2024, 20:46 ET NeuroDerm annonce la publication des résultats positifs de...19 MAR, 2024, 20:46 ETNeuroDerm annonce la publication des résultats positifs de l'essai BouNDless de p...19 MAR, 2024, 20:46 ET NeuroDerm annonce la publication des résultats positifs de...19 MAR, 2024, 20:46 ET NeuroDerm annonce la publication des résultats positifs de...19 MAR, 2024, 20:46 ET19 MAR, 2024, 20:46 ET NeuroDerm annonce la publication des résultats positifs de...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/neuroderm-gibt-die-veroffentlichung-posi...19 MAR, 2024, 22:52 ET NeuroDerm gibt die Veröffentlichung positiver Ergebnisse d...19 MAR, 2024, 22:52 ETNeuroDerm gibt die Veröffentlichung positiver Ergebnisse der Phase-3-Studie BouND...19 MAR, 2024, 22:52 ET NeuroDerm gibt die Veröffentlichung positiver Ergebnisse d...19 MAR, 2024, 22:52 ET NeuroDerm gibt die Veröffentlichung positiver Ergebnisse d...19 MAR, 2024, 22:52 ET19 MAR, 2024, 22:52 ET NeuroDerm gibt die Veröffentlichung positiver Ergebnisse d...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/neuroderm-oznamuje-zverejnenie-pozitivny...19 MAR, 2024, 15:04 ET NeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. ...19 MAR, 2024, 15:04 ETNeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. fázy 3 štúdie BouNDless...19 MAR, 2024, 15:04 ET NeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. ...19 MAR, 2024, 15:04 ET NeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. ...19 MAR, 2024, 15:04 ET19 MAR, 2024, 15:04 ET NeuroDerm oznamuje zverejnenie pozitívnych výsledkov z 3. ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-announces-results-of...21 MAR, 2024, 13:57 ET NRx Pharmaceuticals Announces Results of the Vote Held Dur...NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ...21 MAR, 2024, 13:57 ET21 MAR, 2024, 13:57 ET NRx Pharmaceuticals Announces Results of the Vote Held Dur...NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ...21 MAR, 2024, 13:57 ET NRx Pharmaceuticals Announces Results of the Vote Held Dur...21 MAR, 2024, 13:57 ET21 MAR, 2024, 13:57 ET NRx Pharmaceuticals Announces Results of the Vote Held Dur...NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-to-report-fourth-qua...21 MAR, 2024, 16:02 ET NRx Pharmaceuticals to Report Fourth Quarter and Full Year...NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ...21 MAR, 2024, 16:02 ET21 MAR, 2024, 16:02 ET NRx Pharmaceuticals to Report Fourth Quarter and Full Year...NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ...21 MAR, 2024, 16:02 ET NRx Pharmaceuticals to Report Fourth Quarter and Full Year...21 MAR, 2024, 16:02 ET21 MAR, 2024, 16:02 ET NRx Pharmaceuticals to Report Fourth Quarter and Full Year...NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/ocumension-01477-hk-invests-over-rmb-123...21 MAR, 2024, 10:42 ET OcuMension (01477.HK) Invests Over RMB 123.8 Million in Re...On the evening of March 21st, OcuMension Therapeutics (Shanghai) Co., Ltd. (01477...21 MAR, 2024, 10:42 ET21 MAR, 2024, 10:42 ET OcuMension (01477.HK) Invests Over RMB 123.8 Million in Re...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/oncohost-wins-2024-artificial-intelligen...20 MAR, 2024, 09:00 ET OncoHost Wins 2024 Artificial Intelligence Excellence Awar...The Business Intelligence Group today announced that OncoHost, a technology compa...20 MAR, 2024, 09:00 ET20 MAR, 2024, 09:00 ET OncoHost Wins 2024 Artificial Intelligence Excellence Awar...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/parenteral-nutrition-market-global-analy...19 MAR, 2024, 18:30 ET Parenteral Nutrition Market Global Analysis and Forecasts ...The "Parenteral Nutrition Market: Global Industry Analysis, Trends, Market Size, ...19 MAR, 2024, 18:30 ET19 MAR, 2024, 18:30 ET Parenteral Nutrition Market Global Analysis and Forecasts ...The "Parenteral Nutrition Market: Global Industry Analysis, Trends, Market Size, ...19 MAR, 2024, 18:30 ET Parenteral Nutrition Market Global Analysis and Forecasts ...19 MAR, 2024, 18:30 ET19 MAR, 2024, 18:30 ET Parenteral Nutrition Market Global Analysis and Forecasts ...The "Parenteral Nutrition Market: Global Industry Analysis, Trends, Market Size, ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/payerpro360-by-thelansis--ai-powered-too...20 MAR, 2024, 03:26 ET PayerPro360 by Thelansis - AI-Powered Tool Streamlining Pa...Thelansis Knowledge Partners, specialized in pharmaceutical and biopharmaceutical...20 MAR, 2024, 03:26 ET20 MAR, 2024, 03:26 ET PayerPro360 by Thelansis - AI-Powered Tool Streamlining Pa...Thelansis Knowledge Partners, specialized in pharmaceutical and biopharmaceutical...20 MAR, 2024, 03:26 ET PayerPro360 by Thelansis - AI-Powered Tool Streamlining Pa...20 MAR, 2024, 03:26 ET20 MAR, 2024, 03:26 ET PayerPro360 by Thelansis - AI-Powered Tool Streamlining Pa...Thelansis Knowledge Partners, specialized in pharmaceutical and biopharmaceutical...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/phanes-therapeutics-pt886-granted-fast-t...20 MAR, 2024, 18:09 ET Phanes Therapeutics' PT886 granted Fast Track designation ...Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on i...20 MAR, 2024, 18:09 ET20 MAR, 2024, 18:09 ET Phanes Therapeutics' PT886 granted Fast Track designation ...Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on i...20 MAR, 2024, 18:09 ET Phanes Therapeutics' PT886 granted Fast Track designation ...20 MAR, 2024, 18:09 ET20 MAR, 2024, 18:09 ET Phanes Therapeutics' PT886 granted Fast Track designation ...Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on i...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/pharmacogenomics-research-report-2024-gl...19 MAR, 2024, 17:45 ET Pharmacogenomics Research Report 2024: Global Market to Re...The "Global Pharmacogenomics Market by Offering (Instrument, Consumables, Softwar...19 MAR, 2024, 17:45 ET19 MAR, 2024, 17:45 ET Pharmacogenomics Research Report 2024: Global Market to Re...The "Global Pharmacogenomics Market by Offering (Instrument, Consumables, Softwar...19 MAR, 2024, 17:45 ET Pharmacogenomics Research Report 2024: Global Market to Re...19 MAR, 2024, 17:45 ET19 MAR, 2024, 17:45 ET Pharmacogenomics Research Report 2024: Global Market to Re...The "Global Pharmacogenomics Market by Offering (Instrument, Consumables, Softwar...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/poseida-therapeutics-to-present-at-hc-wa...19 MAR, 2024, 16:05 ET Poseida Therapeutics to Present at H.C. Wainwright 2nd Ann...Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy...19 MAR, 2024, 16:05 ET19 MAR, 2024, 16:05 ET Poseida Therapeutics to Present at H.C. Wainwright 2nd Ann...Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy...19 MAR, 2024, 16:05 ET Poseida Therapeutics to Present at H.C. Wainwright 2nd Ann...19 MAR, 2024, 16:05 ET19 MAR, 2024, 16:05 ET Poseida Therapeutics to Present at H.C. Wainwright 2nd Ann...Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/precigen-reports-full-year-2023-financia...19 MAR, 2024, 16:05 ET Precigen Reports Full Year 2023 Financial Results and Busi...Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the de...19 MAR, 2024, 16:05 ET19 MAR, 2024, 16:05 ET Precigen Reports Full Year 2023 Financial Results and Busi...Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the de...19 MAR, 2024, 16:05 ET Precigen Reports Full Year 2023 Financial Results and Busi...19 MAR, 2024, 16:05 ET19 MAR, 2024, 16:05 ET Precigen Reports Full Year 2023 Financial Results and Busi...Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the de...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/regulus-therapeutics-reports-fourth-quar...21 MAR, 2024, 16:05 ET Regulus Therapeutics Reports Fourth Quarter and Year-End 2...Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on ...21 MAR, 2024, 16:05 ET21 MAR, 2024, 16:05 ET Regulus Therapeutics Reports Fourth Quarter and Year-End 2...Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on ...21 MAR, 2024, 16:05 ET Regulus Therapeutics Reports Fourth Quarter and Year-End 2...21 MAR, 2024, 16:05 ET21 MAR, 2024, 16:05 ET Regulus Therapeutics Reports Fourth Quarter and Year-End 2...Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/renibus-announces-leadership-transition-...21 MAR, 2024, 08:00 ET Renibus Announces Leadership TransitionRenibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company foc...21 MAR, 2024, 08:00 ET21 MAR, 2024, 08:00 ET Renibus Announces Leadership TransitionRenibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company foc...21 MAR, 2024, 08:00 ET Renibus Announces Leadership Transition21 MAR, 2024, 08:00 ET21 MAR, 2024, 08:00 ET Renibus Announces Leadership TransitionRenibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company foc...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/rx-outreach-builds-first-st-louis-commun...19 MAR, 2024, 10:10 ET Rx Outreach builds first St. Louis community pharmacy in p...Rx Outreach, the country's largest nonprofit digital pharmacy, will host a ribbon...19 MAR, 2024, 10:10 ET19 MAR, 2024, 10:10 ET Rx Outreach builds first St. Louis community pharmacy in p...Rx Outreach, the country's largest nonprofit digital pharmacy, will host a ribbon...19 MAR, 2024, 10:10 ET Rx Outreach builds first St. Louis community pharmacy in p...19 MAR, 2024, 10:10 ET19 MAR, 2024, 10:10 ET Rx Outreach builds first St. Louis community pharmacy in p...Rx Outreach, the country's largest nonprofit digital pharmacy, will host a ribbon...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/sciencemedia-welcomes-visionary-leaders-...21 MAR, 2024, 07:30 ET ScienceMedia Welcomes Visionary Leaders to Advisory Board,...ScienceMedia, a global SaaS provider redefining the landscape of clinical mastery...21 MAR, 2024, 07:30 ET21 MAR, 2024, 07:30 ET ScienceMedia Welcomes Visionary Leaders to Advisory Board,...ScienceMedia, a global SaaS provider redefining the landscape of clinical mastery...21 MAR, 2024, 07:30 ET ScienceMedia Welcomes Visionary Leaders to Advisory Board,...21 MAR, 2024, 07:30 ET21 MAR, 2024, 07:30 ET ScienceMedia Welcomes Visionary Leaders to Advisory Board,...ScienceMedia, a global SaaS provider redefining the landscape of clinical mastery...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/seegene-et-springer-nature-annoncent-les...20 MAR, 2024, 00:27 ET Seegene et Springer Nature annoncent les lauréats du progr...20 MAR, 2024, 00:27 ETSeegene et Springer Nature annoncent les lauréats du programme d'open innovation20 MAR, 2024, 00:27 ET Seegene et Springer Nature annoncent les lauréats du progr...20 MAR, 2024, 00:27 ET Seegene et Springer Nature annoncent les lauréats du progr...20 MAR, 2024, 00:27 ET20 MAR, 2024, 00:27 ET Seegene et Springer Nature annoncent les lauréats du progr...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/seegene-y-springer-nature-anuncian-los-g...21 MAR, 2024, 03:00 ET Seegene y Springer Nature anuncian los ganadores del Open ...21 MAR, 2024, 03:00 ETSeegene y Springer Nature anuncian los ganadores del Open Innovation Program21 MAR, 2024, 03:00 ET Seegene y Springer Nature anuncian los ganadores del Open ...21 MAR, 2024, 03:00 ET Seegene y Springer Nature anuncian los ganadores del Open ...21 MAR, 2024, 03:00 ET21 MAR, 2024, 03:00 ET Seegene y Springer Nature anuncian los ganadores del Open ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/senhwa-biosciences-announces-first-patie...20 MAR, 2024, 07:00 ET Senhwa Biosciences Announces First Patient Dosed in the Ph...Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on fir...20 MAR, 2024, 07:00 ET20 MAR, 2024, 07:00 ET Senhwa Biosciences Announces First Patient Dosed in the Ph...Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on fir...20 MAR, 2024, 07:00 ET Senhwa Biosciences Announces First Patient Dosed in the Ph...20 MAR, 2024, 07:00 ET20 MAR, 2024, 07:00 ET Senhwa Biosciences Announces First Patient Dosed in the Ph...Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on fir...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/sgo-2024--the-first-published-clinical-d...19 MAR, 2024, 10:00 ET SGO 2024 | The First Published Clinical Data of Nectin-4-T...Mabwell (688062.SH), an innovative-driven biopharmaceutical company with entire i...19 MAR, 2024, 10:00 ET19 MAR, 2024, 10:00 ET SGO 2024 | The First Published Clinical Data of Nectin-4-T...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/spolenost-cognizant-nasadi-u-svych-farma...19 MAR, 2024, 19:24 ET Společnost Cognizant nasadí u svých farmaceutických klient...19 MAR, 2024, 19:24 ETSpolečnost Cognizant nasadí u svých farmaceutických klientů technologie generativ...19 MAR, 2024, 19:24 ET Společnost Cognizant nasadí u svých farmaceutických klient...19 MAR, 2024, 19:24 ET Společnost Cognizant nasadí u svých farmaceutických klient...19 MAR, 2024, 19:24 ET19 MAR, 2024, 19:24 ET Společnost Cognizant nasadí u svých farmaceutických klient...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/systech-launches-innovative-exception-ha...20 MAR, 2024, 16:15 ET Systech Launches Innovative Exception Handling and Rework ...Systech, part of Markem-Imaje and Dover and a leading provider of digital identif...20 MAR, 2024, 16:15 ET20 MAR, 2024, 16:15 ET Systech Launches Innovative Exception Handling and Rework ...Systech, part of Markem-Imaje and Dover and a leading provider of digital identif...20 MAR, 2024, 16:15 ET Systech Launches Innovative Exception Handling and Rework ...20 MAR, 2024, 16:15 ET20 MAR, 2024, 16:15 ET Systech Launches Innovative Exception Handling and Rework ...Systech, part of Markem-Imaje and Dover and a leading provider of digital identif...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/topical-corticosteroids-market-to-grow-b...21 MAR, 2024, 23:36 ET Topical Corticosteroids Market to Grow by USD 1.08 billion...The topical corticosteroids market is set to witness substantial growth over the ...21 MAR, 2024, 23:36 ET21 MAR, 2024, 23:36 ET Topical Corticosteroids Market to Grow by USD 1.08 billion...21 MAR, 2024, 23:36 ETThe topical corticosteroids market is set to witness substantial growth over the ...21 MAR, 2024, 23:36 ET Topical Corticosteroids Market to Grow by USD 1.08 billion...21 MAR, 2024, 23:36 ET21 MAR, 2024, 23:36 ET Topical Corticosteroids Market to Grow by USD 1.08 billion...The topical corticosteroids market is set to witness substantial growth over the ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/trevi-therapeutics-reports-fourth-quarte...20 MAR, 2024, 16:05 ET Trevi Therapeutics Reports Fourth Quarter and Year End 202...Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical compa...20 MAR, 2024, 16:05 ET20 MAR, 2024, 16:05 ET Trevi Therapeutics Reports Fourth Quarter and Year End 202...Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical compa...20 MAR, 2024, 16:05 ET Trevi Therapeutics Reports Fourth Quarter and Year End 202...20 MAR, 2024, 16:05 ET20 MAR, 2024, 16:05 ET Trevi Therapeutics Reports Fourth Quarter and Year End 202...Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical compa...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/tyra-biosciences-reports-fourth-quarter-...19 MAR, 2024, 16:05 ET Tyra Biosciences Reports Fourth Quarter and Full Year 2023...Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company foc...19 MAR, 2024, 16:05 ET19 MAR, 2024, 16:05 ET Tyra Biosciences Reports Fourth Quarter and Full Year 2023...Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company foc...19 MAR, 2024, 16:05 ET Tyra Biosciences Reports Fourth Quarter and Full Year 2023...19 MAR, 2024, 16:05 ET19 MAR, 2024, 16:05 ET Tyra Biosciences Reports Fourth Quarter and Full Year 2023...Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company foc...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/united-states-pharmacy-benefit-managemen...21 MAR, 2024, 21:30 ET United States Pharmacy Benefit Management Market Insights ...The "U.S. Pharmacy Benefit Management (PBM) Market - Focused Insights 2024-2029" ...21 MAR, 2024, 21:30 ET21 MAR, 2024, 21:30 ET United States Pharmacy Benefit Management Market Insights ...The "U.S. Pharmacy Benefit Management (PBM) Market - Focused Insights 2024-2029" ...21 MAR, 2024, 21:30 ET United States Pharmacy Benefit Management Market Insights ...21 MAR, 2024, 21:30 ET21 MAR, 2024, 21:30 ET United States Pharmacy Benefit Management Market Insights ...The "U.S. Pharmacy Benefit Management (PBM) Market - Focused Insights 2024-2029" ...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/us-fda-approves-idorsias-once-daily-tryv...20 MAR, 2024, 08:00 ET US FDA approves Idorsia's once-daily TRYVIO (aprocitentan)...Idorsia Pharmaceuticals U.S. Inc. announced today that the US Food and Drug Admin...20 MAR, 2024, 08:00 ET20 MAR, 2024, 08:00 ET US FDA approves Idorsia's once-daily TRYVIO (aprocitentan)...Idorsia Pharmaceuticals U.S. Inc. announced today that the US Food and Drug Admin...20 MAR, 2024, 08:00 ET US FDA approves Idorsia's once-daily TRYVIO (aprocitentan)...20 MAR, 2024, 08:00 ET20 MAR, 2024, 08:00 ET US FDA approves Idorsia's once-daily TRYVIO (aprocitentan)...Idorsia Pharmaceuticals U.S. Inc. announced today that the US Food and Drug Admin...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/volition-appoints-dr-andrew-retter-as-ch...19 MAR, 2024, 16:30 ET Volition appoints Dr Andrew Retter as Chief Medical Office...VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigeneti...19 MAR, 2024, 16:30 ET19 MAR, 2024, 16:30 ET Volition appoints Dr Andrew Retter as Chief Medical Office...VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigeneti...19 MAR, 2024, 16:30 ET Volition appoints Dr Andrew Retter as Chief Medical Office...19 MAR, 2024, 16:30 ET19 MAR, 2024, 16:30 ET Volition appoints Dr Andrew Retter as Chief Medical Office...VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigeneti...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/wit-legal-releases-new-report-on-2023-ac...20 MAR, 2024, 11:00 ET WIT Legal Releases New Report on 2023 Activities and Trend...WIT Legal ("WIT"), the leading agency representing testifying experts for high-st...20 MAR, 2024, 11:00 ET20 MAR, 2024, 11:00 ET WIT Legal Releases New Report on 2023 Activities and Trend...WIT Legal ("WIT"), the leading agency representing testifying experts for high-st...20 MAR, 2024, 11:00 ET WIT Legal Releases New Report on 2023 Activities and Trend...20 MAR, 2024, 11:00 ET20 MAR, 2024, 11:00 ET WIT Legal Releases New Report on 2023 Activities and Trend...WIT Legal ("WIT"), the leading agency representing testifying experts for high-st...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/world-precision-instruments-partners-wit...20 MAR, 2024, 09:00 ET World Precision Instruments Partners with TotalLab to Intr...World Precision Instruments (WPI) is pleased to announce their strategic partners...20 MAR, 2024, 09:00 ET20 MAR, 2024, 09:00 ET World Precision Instruments Partners with TotalLab to Intr...World Precision Instruments (WPI) is pleased to announce their strategic partners...20 MAR, 2024, 09:00 ET World Precision Instruments Partners with TotalLab to Intr...20 MAR, 2024, 09:00 ET20 MAR, 2024, 09:00 ET World Precision Instruments Partners with TotalLab to Intr...World Precision Instruments (WPI) is pleased to announce their strategic partners...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
https://www.prnewswire.com/news-releases/wykorzystujc-nvidia-bionemo-firma-cogniz...19 MAR, 2024, 10:51 ET Wykorzystując NVIDIA BioNeMo, firma Cognizant zamierza zas...19 MAR, 2024, 10:51 ETWykorzystując NVIDIA BioNeMo, firma Cognizant zamierza zastosować generatywną szt...19 MAR, 2024, 10:51 ET Wykorzystując NVIDIA BioNeMo, firma Cognizant zamierza zas...19 MAR, 2024, 10:51 ET Wykorzystując NVIDIA BioNeMo, firma Cognizant zamierza zas...19 MAR, 2024, 10:51 ET19 MAR, 2024, 10:51 ET Wykorzystując NVIDIA BioNeMo, firma Cognizant zamierza zas...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/...2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC2024-03-22 05:27:45 UTC
Data source unique ID
n129689_754199c098e7114d0e7f9b72f41a3c52eses
Privacy
Public
Last ran status
COMPLETED
Last ran
2024-03-22 05:27:45 UTC
Crawl Frequency
Not scheduled
Urls to Monitor
Use default URL in recipe

Sample code snippets to quickly import data set into your application

For more information on how to automatically trigger an import please reference our WebHook API guide


Integrating with Java

import java.io.BufferedReader;
import java.io.InputStreamReader;
import java.net.URL;
import java.net.URLConnection;
import java.util.Arrays;

public class HelloWorld {
  public static void main(String[] args) {

    try {
      URL urlCSV = new URL(
        "https://cache.getdata.io/n129689_754199c098e7114d0e7f9b72f41a3c52eses/latest_all.csv"
      );

      URLConnection urlConn = urlCSV.openConnection();
      InputStreamReader inputCSV = new InputStreamReader(
        ((URLConnection) urlConn).getInputStream()
      );
      BufferedReader br = new BufferedReader(inputCSV);

      String line;
      String[] fields;
      while ((line = br.readLine()) != null) {
        // Each row
        fields = line.split(",");
        System.out.println(Arrays.toString(fields));

      }
      // clean up buffered reader
      br.close();


    } catch (Exception e) {
      System.out.println(e.getMessage());
    }
  }   
}


Integrating with NodeJs

const csv     = require('csv-parser');
const https   = require('https');
const fs      = require('fs');

const file = fs.createWriteStream("temp_download.csv");
const request = https.get(
  "https://cache.getdata.io/n129689_754199c098e7114d0e7f9b72f41a3c52eses/latest_all.csv", 
  function(response) {
    response.pipe(file);
  }
);

file.on('finish', function() {
  file.close();
  fs.createReadStream('temp_download.csv').pipe(csv()).on('data', (row) => {
    // Each row
    console.log(row);

  }).on('end', () => {
    console.log('CSV file successfully processed');

  });
});



Integrating with PHP

$data = file_get_contents("https://cache.getdata.io/n129689_754199c098e7114d0e7f9b72f41a3c52eses/latest_all.csv");
$rows = explode("\n",$data);
$s = array();
foreach($rows as $row) {

  # Each row
  var_dump( $row);
  
}


Integrating with Python

import csv
import urllib2

url = 'https://cache.getdata.io/n129689_754199c098e7114d0e7f9b72f41a3c52eses/latest_all.csv'
response = urllib2.urlopen(url)
cr = csv.reader(response)

for row in cr:
  # Each row
  print row


Integrating with Ruby

require 'open-uri'
require 'tempfile'
require 'csv'

temp_file = Tempfile.new( "getdata", :encoding => 'ascii-8bit')
temp_file << open("https://cache.getdata.io/n129689_754199c098e7114d0e7f9b72f41a3c52eses/latest_all.csv").read
temp_file.rewind

CSV.foreach( open(uri), :headers => :first_row ).each do |row|      
  # Each row
  puts row
end

Piyush Ruhela owner

Related Data Sources

dji.com

Charge It, Steady It, Shoot It: Power Stations & iPhone Gimbals for Epic Content

created on 2025-07-02

DJI
116
onlineyedekparca.com

Opel Yedek Parça Fiyatları ve Modelleri - OnlineYedekParca.com

created on 2025-07-02

fevzi KESER
1
19
nisaotobursa.com

BURSA NİSA OTOMOTİV SAN.TİC.LTD.ŞTİ - Otomasyon

created on 2025-07-02

fevzi KESER
1
35
onlineyedekparca.com

Online Yedek Parça (Resmi Web Sitesi) - onlineyedekparca.com

created on 2025-07-02

fevzi KESER
1
16
More related data sources